MedPath

Evaluation of Pétale® (Small Hearing Test Equipment for Children) for the Screening of Hearing Disorders in Children From 9 Months to 3 Years Old by the General Practitioner or Pediatrician

Not Applicable
Conditions
Petale
Hearing Disorders
Child Development
Interventions
Device: Petale
Registration Number
NCT05117801
Lead Sponsor
Ramsay Générale de Santé
Brief Summary

The aim of this study is to confirm the value of this new version of Pétale® ((small equipment for testing the child's hearing) in the daily practice of general practitioners or pediatricians for the screening of hearing disorders in very young children.

Detailed Description

The research procedure is auditory stimulation using Pétale® (small equipment for testing the child's hearing) based on the "orientation reflex" ("Ewing" test): the child is seated on the companion's knees between the two enclosures and the investigator observes whether or not he is attracted to a familiar calibrated noise coming from one side or the other.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
300
Inclusion Criteria
  • Chil, girl or boy between 9 months and 3 years-old
  • Child seen in consultation by a general practitioner or a pediatrician whatever the reason for consultation
  • Child attached to a beneficiary of a social security scheme
  • Signature of informed consent by parents.
Exclusion Criteria
  • Age greater than 3 years and less than 9 months
  • Refusal of one or more parents during the consultation
  • State of the child which does not allow the screening test to be carried out

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
children at the general practitioner or pediatricianPetaleChildren between 9 months and 3 years-old coming to their doctor for any consultation
Primary Outcome Measures
NameTimeMethod
Positive Predictive Value (PPV):2 weeks

Proportion of children with hearing impairment assessed by both investigator and ENT among children with hearing impairment assessed by ENT.

Sensitivity2 weeks

Proportion of children with a hearing impairment assessed by the investigator knowing that they were also assessed with a hearing impairment by ENT specialist.

Specificity2 weeks

Proportion of children without hearing impairment assessed by the investigator knowing that they were also assessed without hearing impairment by ENT.

Negative Predictive Value (NPV)2 weeks

Proportion of children without hearing impairment assessed by both investigator and ENT among children without hearing impairment assessed by ENT.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinique Saint-Amé

🇫🇷

Lambres-lez-Douai, France

© Copyright 2025. All Rights Reserved by MedPath